Natera, Inc. (45E)

Profile

https://www.natera.com

Natera, Inc. is a clinical genetic testing company that focuses on advanced molecular diagnostics using cell-free DNA technology. The company develops and commercializes tests that support clinical decision-making in oncology, women’s health, and organ health, helping physicians tailor care based on genetic insights. In women’s health, Natera, Inc. offers non-invasive prenatal tests and other reproductive genetic assessments designed to evaluate fetal and maternal health risk factors. In oncology, its assays analyze tumor-derived genetic material to inform cancer detection, monitoring, and treatment response. In organ health, the company provides tests that assess transplant rejection risk and genetic contributions to chronic kidney and other organ-related conditions. Natera, Inc., headquartered in the United States, serves hospitals, clinics, and specialist practices, integrating its testing solutions into existing care pathways to support more precise, data-driven medical decisions worldwide.